API0233015

Deucravacitinib

Deucravacitinib is used for the treatment of psoriasis.

Product Size

Quantity

Pharm Gradet

Standard

Registration

Inquiry

API Description

API Details

Document

Related Patent Status

Molecular Weight (g/mol)

425.5
Molecular Formula

C20H22N8O3
InChI

InChI=1S/C20H22N8O3/c1-21-20(30)16-14(9-15(25-26-16)24-19(29)11-7-8-11)23-13-6-4-5-12(17(13)31-3)18-22-10-28(2)27-18/h4-6,9-11H,7-8H2,1-3H3,(H,21,30)(H2,23,24,25,29)/i1D3
InChIKey

BZZKEPGENYLQSC-FIBGUPNXSA-N
SMILES

[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4
IUPAC Name

6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
Exact Mass (Da)

425.20031683
Monoisotopic Mass (Da)

425.20031683

OUR PRODUCTS